
Pubmed-entry ::= {
  pmid 29877701,
  medent {
    em std {
      year 2018,
      month 6,
      day 8,
      hour 6,
      minute 0
    },
    cit {
      title {
        name "alpha-Helix or beta-Turn? An Investigation into N-Terminally
 Constrained Analogues of Glucagon-like Peptide 1 (GLP-1) and Exendin-4."
      },
      authors {
        names std {
          {
            name ml "Oddo A",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "Mortensen S",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "Thogersen H",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "De Maria L",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "Hennen S",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "McGuire JN",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "Kofoed J",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "Linderoth L",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          },
          {
            name ml "Reedtz-Runge S",
            affil str "Global Research , Novo Nordisk A/S , Novo Nordisk Park
 , 2760 Malov , Denmark."
          }
        }
      },
      from journal {
        title {
          iso-jta "Biochemistry",
          ml-jta "Biochemistry",
          issn "1520-4995",
          name "Biochemistry"
        },
        imp {
          date std {
            year 2018,
            month 7,
            day 17
          },
          volume "57",
          issue "28",
          pages "4148-4154",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2018,
                month 6,
                day 8,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2019,
                month 4,
                day 4,
                hour 6,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2018,
                month 6,
                day 8,
                hour 6,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pubmed 29877701,
        doi "10.1021/acs.biochem.8b00105",
        other {
          db "ELocationID doi",
          tag str "10.1021/acs.biochem.8b00105"
        }
      }
    },
    abstract "Peptide agonists acting on the glucagon-like peptide 1 receptor
 (GLP-1R) promote glucose-dependent insulin release and therefore represent
 important therapeutic agents for type 2 diabetes (T2D). Previous data
 indicated that an N-terminal type II beta-turn motif might be an important
 feature for agonists acting on the GLP-1R. In contrast, recent publications
 reporting the structure of the full-length GLP-1R have shown the N-terminus
 of receptor-bound agonists in an alpha-helical conformation. To reconcile
 these conflicting results, we prepared N-terminally constrained analogues of
 glucagon-like peptide 1 (GLP-1) and exendin-4 and evaluated their receptor
 affinity and functionality in vitro; we then examined their crystal
 structures in complex with the extracellular domain of the GLP-1R and used
 molecular modeling and molecular dynamics simulations for further
 investigations. We report that the peptides' N-termini in all determined
 crystal structures adopted a type II beta-turn conformation, but in vitro
 potency varied several thousand-fold across the series. Potency correlated
 better with alpha-helicity in our computational model, although we have found
 that the energy barrier between the two mentioned conformations is low in our
 most potent analogues and the flexibility of the N-terminus is highlighted by
 the dynamics simulations.",
    mesh {
      {
        term "Amino Acid Sequence"
      },
      {
        term "Animals"
      },
      {
        term "Cell Line"
      },
      {
        term "Crystallography, X-Ray"
      },
      {
        term "Exenatide",
        qual {
          {
            mp TRUE,
            subh "analogs & derivatives"
          },
          {
            subh "chemistry"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Glucagon-Like Peptide 1",
        qual {
          {
            mp TRUE,
            subh "analogs & derivatives"
          },
          {
            subh "chemistry"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Glucagon-Like Peptide-1 Receptor",
        qual {
          {
            subh "chemistry"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Molecular Dynamics Simulation"
      },
      {
        term "Protein Conformation, alpha-Helical"
      },
      {
        term "Protein Conformation, beta-Strand"
      },
      {
        term "Protein Domains"
      }
    },
    substance {
      {
        type nameonly,
        name "Glucagon-Like Peptide-1 Receptor"
      },
      {
        type cas,
        cit "89750-14-1",
        name "Glucagon-Like Peptide 1"
      },
      {
        type cas,
        cit "9P1872D4OL",
        name "Exenatide"
      }
    },
    pmid 29877701,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}


